Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04583800

Prediction of Heart Failure and Cognitive Decline in Type 2 Diabetes

Prediction of Heart Failure and Cognitive Decline in Type 2 Diabetes : Longitudinal Cohort Study of Immuno-inflammation, Cardiac Energetics and Cognition.PreciDIAB-HEART&BRAIN

Status
Recruiting
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Type 2 diabetes is a risk factor of heart failure and cognitive decline. Heart failure at its early stage is often silent. At present, primary prevention for heart failure is not available. Our aim is to identify diabetic patients at risk of heart failure in order to develop personalized preventive strategies. Type 2 diabetes is vascular and metabolic risk factor for cognitive decline though a direct lesional effect but also through an interaction with underlying neurodegenerative lesions. Our aim is to identify diabetic patients at risk of cognitive decline in order to develop personalized preventive strategies

Conditions

Timeline

Start date
2021-06-22
Primary completion
2026-06-01
Completion
2026-06-01
First posted
2020-10-12
Last updated
2025-12-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04583800. Inclusion in this directory is not an endorsement.